Roche (RHHBY) expects an increase in Group sales in the mid single digit range at CER. Core earnings per share are targeted to develop in the high single digit range at CER. Roche expects to further increase its dividend in Swiss francs.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RHHBY:
- Roche reports Q1 group sales CHF 15.4B vs. CHF 14.4B last year
- Trump looking at cutting drug prices to international levels, Reuters says
- Regeneron price target lowered to $850 from $1,152 at Canaccord
- Roche to invest $50B in pharmaceuticals, diagnostics in the U.S. over 5 years
- Swiss Drugmaker Roche (RHHBY) Announces $50B Investment in U.S. to Combat Tariff Threats